EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Reduced-dose alternate-day oral iron supplementation in women with iron deficiency: a randomized controlled trial

Maria Chiara Valerii, Nikolas Kostantine Dussias, Anna Perri, Renato Spigarelli, Alberto Bernacchi, Fernando Rizzello, Gianluigi Magri, Paolo Gionchetti, Enzo Spisni iD

European Journal of Nutrition · 2026

DOI: 10.1007/s00394-026-04139-9 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Nutrition, 2026. Verfasst von Maria Chiara Valerii und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological, Geological and Environmental Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Dietary Supplements, Iron, Anemia, Iron-Deficiency. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Università di Bologna, Diadema Farmaceutici Srl.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Oral iron supplementation is frequently limited by gastrointestinal side effects and reduced absorption associated with hepcidin-mediated regulation. This randomized, parallel-group, active-controlled study evaluated whether a reduced-dose alternate-day oral iron supplementation strategy could improve iron status in women with iron deficiency.

Methods

Sixty-six iron-deficient women of reproductive age (18–50 years; serum ferritin < 30 ng/mL) were randomized to receive, for 42 days, either micronized, dispersible ferric pyrophosphate providing 21 mg of elemental iron every 48 h combined with a daily gut microbiota modulator, or sucrosomial ferric pyrophosphate providing 30 mg of elemental iron per day. The primary endpoint was serum ferritin, while secondary endpoints included serum iron, transferrin, transferrin saturation (TSAT), total iron-binding capacity (TIBC), hemoglobin, and red blood cell count.

Results

Serum ferritin increased significantly over time in both groups ( p < 0.001), with no significant differences between treatments. Comparable improvements were observed for serum iron, transferrin, TSAT, and TIBC, while hemoglobin remained stable throughout the study. Both interventions were generally well tolerated, with only mild transient gastrointestinal adverse events and no clinically relevant changes in inflammatory markers.

Conclusion

A reduced-dose alternate-day oral iron supplementation strategy achieved improvements in iron status comparable to standard daily supplementation despite lower cumulative iron exposure. These findings support the potential clinical relevance of physiologically informed low-dose iron supplementation strategies in women with iron deficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsIronAnemia, Iron-DeficiencyHumansFemaleAdultMiddle AgedYoung AdultAdolescentFerritinsAdministration, OralTransferrinDiphosphatesHemoglobins

Stichwörter der Autor:innen

Alternate-day dosingFerritinGut microbiotaIron bioavailabilityIron deficiencyOral iron supplementation

Substanzen

FerritinsIronTransferrinferric pyrophosphateDiphosphatesHemoglobins

Autor:innen und Institutionen

  • Department of Biological, Geological and Environmental Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • IBD Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Pharmacy and Health and Nutrition Sciences, University of Calabria, 87030, Rende, Cosenza, Italy.
  • Diadema Farmaceutici Srl, Via Gaetano Malasoma 28, 56121, Pisa, Italy.
  • Department of Biological, Geological and Environmental Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. enzo.spisni@unibo.it.

ORCID-Profile: Enzo Spisni

Förderung

  • Università di Bologna
  • Diadema Farmaceutici Srl

Zitieren

APA

Valerii, M. C., Dussias, N. K., Perri, A., Spigarelli, R., Bernacchi, A., Rizzello, F., Magri, G., Gionchetti, P., & Spisni, E. (2026). Reduced-dose alternate-day oral iron supplementation in women with iron deficiency: a randomized controlled trial. European Journal of Nutrition. https://doi.org/10.1007/s00394-026-04139-9

Vancouver

Valerii MC, Dussias NK, Perri A, Spigarelli R, Bernacchi A, Rizzello F, et al. Reduced-dose alternate-day oral iron supplementation in women with iron deficiency: a randomized controlled trial. European Journal of Nutrition. 2026. doi:10.1007/s00394-026-04139-9

BibTeX
@article{Valerii2026,
  author = {Valerii, Maria Chiara and Dussias, Nikolas Kostantine and Perri, Anna and Spigarelli, Renato and Bernacchi, Alberto and Rizzello, Fernando and Magri, Gianluigi and Gionchetti, Paolo and Spisni, Enzo},
  title = {Reduced-dose alternate-day oral iron supplementation in women with iron deficiency: a randomized controlled trial},
  journal = {European Journal of Nutrition},
  year = {2026},
  doi = {10.1007/s00394-026-04139-9}
}
Kostenlos starten →